Monday, October 18, 2004

Medicine: Monkey See Monkey Do

Since Merck lost its cash cow Cox-2 inhibitor Vioxx, Pfizer is sponsoring a large new clinical trial to assess the cardiovascular safety of Celebrex. Shame we'll have to wait two years to know anything.

No comments: